The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

In a major advancement in the global fight against HIV, the World Health Organization (WHO) has recommended the use of ...

If an HIV-negative person takes PrEP daily and is exposed to the virus, the medication can prevent the virus from taking hold in their body. This mechanism makes PrEP a powerful tool in the fight ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

JOHANNESBURG (AP) — Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV ...

Beyoncé and her family are using their platform to revive a conversation we still need: how to stop new infections, especially among women of color.

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear ...

Republicans are pulling critical resources that help prevent HIV. With the crisis still underway, Republicans are pulling critical resources. Two recent incidents typify their attack.

A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.